Jasper Therapeutics, Inc. - JSPR

SEC FilingsOur JSPR Tweets

About Gravity Analytica

Recent News

  • 09.09.2025 - H.C. Wainwright 27th Annual Global Investment Conference
  • 09.09.2025 - H.C. Wainwright 27th Annual Global Investment Conference
  • 09.03.2025 - Cantor Fitzgerald Global Healthcare Conference 2025
  • 09.03.2025 - Cantor Fitzgerald Global Healthcare Conference 2025
  • 08.27.2025 - Jasper Therapeutics to Present at Upcoming Investor Conferences
  • 08.27.2025 - Jasper Therapeutics to Present at Upcoming Investor Conferences
  • 08.13.2025 - Jasper Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update
  • 08.13.2025 - Jasper Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update
  • 07.09.2025 - Jasper Therapeutics Announces Corporate Reorganization and Other Cost Cutting Measures to Extend Cash Runway
  • 07.09.2025 - Jasper Therapeutics Announces Corporate Reorganization and Other Cost Cutting Measures to Extend Cash Runway

Recent Filings

  • 08.13.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
  • 08.13.2025 - 8-K Current report
  • 08.13.2025 - EX-99.1 EX-99.1
  • 08.06.2025 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
  • 07.17.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
  • 07.11.2025 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
  • 07.09.2025 - EX-99.1 EX-99.1
  • 07.09.2025 - 8-K Current report